Literature DB >> 31848918

Endometrial cancer and its cell lines.

Kristijan Skok1,2, Uroš Maver3,4, Lidija Gradišnik3, Nejc Kozar5,6, Iztok Takač5,6, Darja Arko7,8.   

Abstract

Endometrial cancer is one of the most common gynaecological malignancies worldwide. One type of research in this field is the growing of cell lines (CLs) and cultures, which can be used to explore the biological mechanisms of cancer. The purpose of this review is to offer an overview of the current literature and highlight the importance of correct CL studies. We carried out a literature analysis of more than 60 articles from the Pubmed, Medline databases that were almost exclusively published in indexed journals in the last 10 years as well as the primary originating scientific studies of specific CLs. We then summarized the newest findings and recommendations. Cell lines are becoming widely used as in vitro tumour models. Recent work has shown inconsistencies in nomenclature and culturing of CLs. Their genomic evolution leads to a high degree of variation across CL strains therefore it is of the utmost importance to recognize the variability within laboratory cancer models. Laboratories must adapt, incorporate additional characterisation techniques and view this situation as an opportunity to improve the reproducibility of pre-clinical cancer research. The authors offer a comprehensive literature review about endometrial cancer CLs, a review of the current literature and advice on culturing CLs.

Entities:  

Keywords:  Cancer cell line; Cell isolation; Cell line; Endometrial cancer; In vitro models; Tissue culture

Mesh:

Year:  2019        PMID: 31848918     DOI: 10.1007/s11033-019-05226-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  5 in total

Review 1.  Strategies for modelling endometrial diseases.

Authors:  Alina R Murphy; Hannes Campo; J Julie Kim
Journal:  Nat Rev Endocrinol       Date:  2022-09-01       Impact factor: 47.564

2.  Expression Profile of mRNAs and miRNAs Related to the Oxidative-Stress Phenomenon in the Ishikawa Cell Line Treated Either Cisplatin or Salinomycin.

Authors:  Szymon Januszyk; Paweł Mieszczański; Hubert Lurka; Dorota Sagan; Dariusz Boroń; Beniamin Oskar Grabarek
Journal:  Biomedicines       Date:  2022-05-20

Review 3.  Gynaecological cancers and their cell lines.

Authors:  Kristijan Skok; Lidija Gradišnik; Uroš Maver; Nejc Kozar; Monika Sobočan; Iztok Takač; Darja Arko; Rajko Kavalar
Journal:  J Cell Mol Med       Date:  2021-03-02       Impact factor: 5.310

4.  MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines.

Authors:  Kristijan Skok; Lidija Gradišnik; Helena Čelešnik; Marko Milojević; Uroš Potočnik; Gregor Jezernik; Mario Gorenjak; Monika Sobočan; Iztok Takač; Rajko Kavalar; Uroš Maver
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

5.  Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells.

Authors:  Molly Dore; Sara Filoche; Kirsty Danielson; Claire Henry
Journal:  Cancer Manag Res       Date:  2021-10-14       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.